A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

NCT02614547 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Postpartum Depression

Interventions

DRUG: SAGE-547
DRUG: Placebo

Sponsor

Supernus Pharmaceuticals, Inc.